Hemoglobin-to-Red Cell Distribution Width Ratio as a Prognostic Marker in Decompensated Heart Failure Patients: A Prospective Observational Study
Life · 27.03.2026 · 16 (4) · 551
DOI: 10.3390/life16040551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 27.03.2026. Verfasst von Ruxandra Maria Christodorescu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department V-Internal Medicine 1, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babes University of Medicine and Pharmacy Timisoara https://ror.org/00afdp487.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background and Methods: This prospective observational study investigated the prognostic value of the hemoglobin-to-red cell distribution width ratio (HRR) in 278 patients hospitalized with decompensated heart failure (HF). The primary endpoint was a composite of all-cause mortality or HF rehospitalization at 12 months. Multivariable Cox regression was employed to adjust for risk factors including age, sex, NT-proBNP, LVEF, and eGFR.
Results
The median HRR was 0.89. During follow-up, the primary endpoint occurred in 167 (60.1%) patients. Unadjusted analysis showed a lower HRR was significantly associated with reduced event-free survival (log-rank p = 0.027). However, after multivariable adjustment, this association was no longer statistically significant (p = 0.240). Older age and male sex remained independent predictors.
Conclusions
In patients with decompensated HF, a lower baseline HRR correlates with increased risk but does not maintain independent prognostic value after adjusting for powerful confounders. HRR may serve as a simple, initial marker of risk rather than an independent predictor.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department V-Internal Medicine 1, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
- Research Centre of Timisoara Institute of Cardiovascular Diseases, Gheorghe Adam St., No. 13A, 300310 Timisoara, Romania.
- Department III-Functional Sciences-Medical Informatics and Biostatistics, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
- Multidisciplinary Heart Research Center, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
- Multidisciplinary Doctoral School, Vasile Goldis Western University of Arad, 310025 Arad, Romania.
- Cardiology Department, Arad County Clinical Emergency Hospital, 310037 Arad, Romania.
ORCID-Profile: Ruxandra Maria Christodorescu, Călin Muntean
Förderung
- Victor Babes University of Medicine and Pharmacy Timisoara https://ror.org/00afdp487
Zitieren
APA
Christodorescu, R. M., Muntean, C., Andor, M., Lighezan, D., Pop Moldovan, A., Blajevschi, A., Ardelean, S., & Darabanțiu, D. (2026). Hemoglobin-to-Red Cell Distribution Width Ratio as a Prognostic Marker in Decompensated Heart Failure Patients: A Prospective Observational Study. Life, 16(4), 551. https://doi.org/10.3390/life16040551
Vancouver
Christodorescu RM, Muntean C, Andor M, Lighezan D, Pop Moldovan A, Blajevschi A, et al. Hemoglobin-to-Red Cell Distribution Width Ratio as a Prognostic Marker in Decompensated Heart Failure Patients: A Prospective Observational Study. Life. 2026;16(4):551. doi:10.3390/life16040551
BibTeX
@article{Christodorescu2026,
author = {Christodorescu, Ruxandra Maria and Muntean, Călin and Andor, Minodora and Lighezan, Daniel and Pop Moldovan, Adina and Blajevschi, Andrei and Ardelean, Samuel and Darabanțiu, Dan},
title = {Hemoglobin-to-Red Cell Distribution Width Ratio as a Prognostic Marker in Decompensated Heart Failure Patients: A Prospective Observational Study},
journal = {Life},
year = {2026},
volume = {16},
number = {4},
pages = {551},
doi = {10.3390/life16040551}
}
EUVIMED